Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2006
06/21/2006CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives
06/21/2006CN1260222C Antagonists of mcp-1 function and methods of use thereof
06/21/2006CN1260004C Polytype Mg-Al hydrotalcite
06/21/2006CN1259971C Medication for curing stomach trouble and preparation method
06/21/2006CN1259970C Medication for treating discomfort caused by external wind and cold and preparation method
06/21/2006CN1259963C Rosa roxburghii oral liquid and its preparing method
06/21/2006CN1259962C Stomach strengthening and digestion promoting powder, and its preparation process
06/21/2006CN1259960C Medication for curing stomach trouble and disease of bills and preparation method
06/21/2006CN1259959C Halth-care product possessing brain-strengthening kidney-tonifying action
06/21/2006CN1259957C Qi strengthening pure Chinese traditional medicine
06/21/2006CN1259953C Anti aging health caring medicine
06/21/2006CN1259944C Preparation of liver protecting liquid
06/21/2006CN1259941C Capsule for promoting male sexual function
06/21/2006CN1259939C Traditional Chinese medicine formulation for oral disease and its preparation method
06/21/2006CN1259937C Health nutrient capsule and its uses
06/21/2006CN1259926C Medicine for preventing allergy of dentin
06/21/2006CN1259925C Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use
06/21/2006CN1259920C Biologically active agents and drugs
06/21/2006CN1259918C Use of bile acid or bile salt fatty acid conjugates
06/21/2006CN1259899C Composite of natural plants extract and uses thereof
06/21/2006CN1259857C Fish stewing seasoning
06/20/2006US7064217 2-Aminoacetamide derivatives with hydroxy-, phosphonate-, and/or methylene phosphonate substituent; antitumor, anticoagulant, antiproliferative, and wound healing agents
06/20/2006US7064204 Nitrogen compounds such as 4-(5-amino-7-phenethyl-7H-pyrazolo (4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-2-yl)-phenol, used as adenosine receptor antagonists, for prophylaxis of nervous, cardiovascular, respiratory, urogenital and immune disorders
06/20/2006US7064189 Antibodies that immunospecifically bind to trail receptors
06/20/2006US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders
06/20/2006US7064147 Amino acids with affinity for the α-2-delta-protein
06/20/2006US7064143 4-oxy- or amino-substituted indole-2-carboxy acids, esters and amides, e.g., ethyl 4-hydroxy-1-methyl-1H-indole-2-carboxylate and N-methyl-N-phenethyl 4-hydroxy-1-methyl-1H-indole-2-carboxamide; used for treatment of Alzheimer's disease, anxiety or schizophrenia
06/20/2006US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders
06/20/2006US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents
06/20/2006US7064134 4-piperidinyl-substituted, e.g., 4-(2-methyl-4-piperidin-1-yl-quinolin-7-ylmethoxy)-benzonitrile; treating eating disorders and obesity
06/20/2006US7064119 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence
06/20/2006US7064115 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
06/20/2006US7063971 Phosphodiesterase enzymes
06/20/2006CA2379633C Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
06/20/2006CA2177392C Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
06/15/2006WO2006062478A1 Novel treatment of gastrointestinal disorders
06/15/2006WO2006062104A1 Bacillus macroides strain and food using the same
06/15/2006WO2006061992A1 Preventive/therapeutic composition for liver disease
06/15/2006WO2005089786A3 Y4 selective receptor agonists for therapeutic interventions
06/15/2006US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP)
06/15/2006US20060128807 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
06/15/2006US20060128776 Opioid receptor active compounds
06/15/2006US20060128760 Use of mglur5 antagonists for the treatment of gerd
06/15/2006US20060128749 Compounds
06/15/2006US20060128745 Chemical compounds
06/15/2006US20060128740 Tricyclic androgen receptor modulator compounds and methods
06/15/2006US20060128721 Novel formulations of opioid-based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
06/15/2006US20060128705 Method of treating chronic fatigue syndrome
06/15/2006US20060128701 N-{4-[ethyl-(2-hydroxy-ethyl)-amino]-phenyl}-2-[4-(2-oxo-4H-benzo[d][1,3]oxazin-1- yl)-piperidin-1-yl]-acetamide; Eating disorders; CNS disorders; antidiabetic agents; psychological disorders; antiepileptic, antiinflammatory agents, autoimmune diseases; neuropeptide Y5 (NPY5) receptor antagonists
06/15/2006US20060128659 Sulfotransferase inhibitors
06/15/2006US20060128639 Regulators of the hedgehog pathway, compositions and uses related thereto
06/15/2006US20060128587 Lipase-containing composition and methods of use thereof
06/15/2006US20060128013 Directed differentiation of embryonic cells
06/15/2006US20060127927 Mammalian IAP gene family, primers, probes, and detection methods
06/15/2006US20060127914 Nicotinic acetylcholine receptor
06/15/2006US20060127507 comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; treating neutropenia and aplastic anemia
06/15/2006US20060127445 Anti-angiogenic compositions and methods of use
06/15/2006US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b
06/15/2006US20060127378 Composition for promoting the proliferation of lactobacillus casei subsp. casei
06/15/2006US20060127353 Fat-binding polymers
06/15/2006US20060127330 Composition for treating and/or preventing periodontal disease
06/15/2006US20060127319 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
06/15/2006CA2589448A1 Substituted imidazo[4,5-b]pyridines as inhibitors of gastric acid secretion
06/14/2006EP1669450A1 Staple type oligonucleotide and drug comprising the same
06/14/2006EP1669441A1 Method of differentiating mesenchymal stem cell into liver cell and artificial human liver cell
06/14/2006EP1669367A1 Peptides which can bind to transforming growth factor beta 1 (tgf-beta1)
06/14/2006EP1669364A2 Methods and compositions for treating hepatitis C virus
06/14/2006EP1669081A1 Apoptotic entities for use in treatment of T-cell-mediated und inflammatory disorders
06/14/2006EP1669080A1 Method of inhibiting alveolar resorption and peridental membrane loss and composition for internal use to be used therein
06/14/2006EP1669077A1 Antibacterial compositions of n-acetyl-d-aminoglycosamine and antibiotics
06/14/2006EP1669076A1 Use of n-acetyl-d-aminoglycosamine in preparation of drugs for modulating microorganisms on mucous membrane
06/14/2006EP1667668A1 Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents
06/14/2006EP1667660A2 Pantoprazole multiparticulate formulations
06/14/2006EP1476434B1 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
06/14/2006EP1476136B1 Pharmaceutical composition comprising n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process for preparing thereof comprising dry granulation
06/14/2006EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
06/14/2006EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy
06/14/2006EP1349836B1 Tetracyclic derivatives as spla2 inhibitors
06/14/2006EP1341770B1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
06/14/2006EP1309703B1 Kallikrein gene
06/14/2006EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
06/14/2006EP1261361B1 Oral, nasal and pulmonary dosage formulations of copolymer 1 (glatiramer acetate)
06/14/2006EP1248595A4 Multi-step drug dosage forms
06/14/2006EP1165085B1 Phthalazine derivatives for treating inflammatory diseases
06/14/2006EP1102596B1 Peptide antagonists of zonulin and methods for use of the same
06/14/2006EP1033129B1 Antimicrobials for treating peptic ulcer
06/14/2006EP0777687B1 Trefoil peptide dimer
06/14/2006EP0699236B2 Purified mammalian flt3 ligands and agonists and antagonists thereof
06/14/2006DE102004059674A1 Transdermal delivery system to treat movement disease and post-operative illness comprises scopolamine and a matrix comprising styrene-butadiene-copolymer-bonding adhesive
06/14/2006CN1787813A Treatment and/or prevention of non-viral epithelial damage
06/14/2006CN1786142A Medicinal wine
06/14/2006CN1786034A Preparation method of umbellate pore fungus polysaccharide sulphate
06/14/2006CN1786001A Composition stable blood porphrin derivative, its preparation method and injection agent
06/14/2006CN1786000A Sodium salt of Entecavir, its preparation method and pharmaceutical application
06/14/2006CN1785429A Medicinal composition for treating peptic ulcer
06/14/2006CN1785420A Topically applied medicine for treating chronic entiritis
06/14/2006CN1785419A Agastachel patchouli qi-righting fast dispersion solid preparation and its preparation method
06/14/2006CN1785418A Xiaojianzhong tablet for treating gastrodynic and its preparation method
06/14/2006CN1785416A Medicinal preparation for freating chololithiasis and its preparation method
06/14/2006CN1785410A Preparation method of ready prepared chinese medicinal granules for treathing pains